Life Sciences Intelligence
The CODEW Intelligence · Technology Intelligence
Life Sciences Intelligence
The living database of life sciences companies, platforms, and technologies
Life Sciences Intelligence is The CODEW's comprehensive life sciences intelligence database — built to track the companies, platforms, and technologies shaping the global life sciences economy. It covers biotechnology, pharmaceuticals, genomics, diagnostics, drug discovery, biomanufacturing, synthetic biology, bioinformatics, and research tools.
This is an industry intelligence directory, not a general science encyclopedia. It prioritizes company names, industry segments, and technology categories — so you can discover who is building what, and where the industry is moving.
- Track the companies: Biotech, pharma, genomics, diagnostics, biomanufacturing, synthetic biology, bioinformatics, and tools
- Identify the emerging players: AI drug discovery, cell and gene therapy, RNA, protein design, and digital biology
- Discover the technologies: CRISPR, sequencing, multi-omics, spatial biology, lab automation, and biomanufacturing innovation
- Understand the competitive landscape: Pipelines, funding, M&A, licensing, manufacturing capacity, and regulatory shifts
Audience: Founders, operators, researchers, investors, and analysts. Part of: The CODEW Intelligence — a main Intelligence, like Startup Intelligence, VC Intelligence, and Business Intelligence. Parent: Industry Intelligence.
Industry Overview — The Global Life Sciences Ecosystem
1. Life sciences is a discovery + development + manufacturing system
Winning is not just a molecule. It is discovery, clinical trials, manufacturing, regulatory approval, and market access — all at once, over years.
2. Platforms beat single products
mRNA, CRISPR, antibody, cell therapy, and AI discovery platforms can produce pipelines. Single-asset companies live or die on one trial.
3. AI, automation, and biomanufacturing are compressing timelines
Computational biology, lab automation, and advanced biomanufacturing are reshaping how fast therapies are discovered, tested, and produced.
Life Sciences Company Directory — All Companies
Official names only. Grouped by segment. Companies that operate across several segments are listed under their primary segment, with cross-reference noted where relevant. Directory is reviewed and expanded monthly.
1. Biotechnology Intelligence
Biological therapies, engineered organisms, cellular technologies, and next-generation biotechnology platforms.
- Amgen — also listed in Pharmaceutical & Drug Development
- Gilead Sciences
- Regeneron Pharmaceuticals
- Moderna
- BioNTech
- Vertex Pharmaceuticals
- CRISPR Therapeutics
- Intellia Therapeutics
- Beam Therapeutics
- Editas Medicine
- Sarepta Therapeutics
- Alnylam Pharmaceuticals
- Genmab
- Argenx
- Biogen
2. Pharmaceutical & Drug Development Intelligence
Pharmaceutical research, drug discovery, development, manufacturing, and commercialization.
- Eli Lilly
- Novo Nordisk
- Pfizer
- Merck & Co.
- Johnson & Johnson
- Roche — also in Diagnostics
- AstraZeneca
- Novartis
- Sanofi
- Bristol Myers Squibb
- AbbVie
- GSK
- Takeda Pharmaceutical
- Bayer
- Boehringer Ingelheim — also in Biomanufacturing
- Daiichi Sankyo
- Amgen — primary listing in Biotechnology
3. Genomics & Precision Medicine Intelligence
DNA sequencing, genetic analysis, genomic research platforms, and precision medicine technologies.
- Illumina
- Pacific Biosciences
- Oxford Nanopore Technologies
- 10x Genomics
- BGI Genomics
- Twist Bioscience — also in Synthetic Biology
- Natera
- Guardant Health
- Exact Sciences
- Tempus AI — also in Bioinformatics & Computational Biology
- Foundation Medicine
- Myriad Genetics
- Qiagen
4. Diagnostics & Laboratory Technology Intelligence
Diagnostic systems, laboratory instruments, testing technologies, and analytical platforms.
- Thermo Fisher Scientific — also in Biomanufacturing and Research Tools
- Danaher — also in Research Tools
- Abbott Laboratories
- Siemens Healthineers
- Roche Diagnostics — part of Roche
- bioMérieux
- QuidelOrtho
- Revvity — also in Research Tools
- Agilent Technologies — also in Research Tools
- Waters Corporation — also in Research Tools
- Bruker — also in Research Tools
- Bio-Rad Laboratories — also in Research Tools
- Hologic
- Becton, Dickinson and Company (BD)
5. Biomanufacturing Intelligence
Biological production, contract development and manufacturing, biologics manufacturing, and specialized production infrastructure.
- Lonza
- Samsung Biologics
- WuXi Biologics
- Catalent
- Fujifilm Diosynth Biotechnologies
- Thermo Fisher Scientific — primary listing in Diagnostics
- Boehringer Ingelheim BioXcellence — part of Boehringer Ingelheim
- Charles River Laboratories
- AGC Biologics
- Siegfried
- Recipharm
6. Synthetic Biology Intelligence
Engineered biological systems, synthetic DNA, cell programming, and industrial biotechnology.
- Ginkgo Bioworks
- Twist Bioscience — primary listing in Genomics
- Zymergen — Historical reference only. Acquired by Ginkgo Bioworks. Not an independent current competitor.
- Codexis
- Amyris — Historical reference only. Do not present as an active independent operating company without verifying current status.
- Genomatica
- Cambrium
- Arzeda
- Solugen
- LanzaTech
- Evonetix
7. Bioinformatics & Computational Biology Intelligence
Computational methods, AI, machine learning, and biological data to accelerate research and drug development.
- Recursion Pharmaceuticals
- Schrödinger
- Insilico Medicine
- Isomorphic Labs
- Generate: Biomedicines
- BenevolentAI
- Owkin
- PathAI
- Benchling
- Dotmatics
- Tempus AI — primary listing in Genomics
- Valo Health
- Atomwise
- XtalPi
- Relation Therapeutics
8. Research Tools & Life Science Infrastructure Intelligence
Laboratory equipment, research tools, reagents, scientific instruments, research software, and laboratory infrastructure.
- Thermo Fisher Scientific — primary listing in Diagnostics
- Danaher — primary listing in Diagnostics
- Agilent Technologies — primary listing in Diagnostics
- Sartorius
- Merck KGaA
- Avantor
- Eppendorf
- Revvity — primary listing in Diagnostics
- Waters Corporation — primary listing in Diagnostics
- Bruker — primary listing in Diagnostics
- Bio-Rad Laboratories — primary listing in Diagnostics
- Tecan
- Mettler-Toledo
- Corning
- Leica Microsystems
Emerging Technologies
Technology areas likely to influence the next generation of life sciences companies — connected to the companies developing and commercializing them.
AI-Driven Drug Discovery Core
AI, machine learning, and generative AI for target discovery, molecule design, and trial design. Companies: Recursion Pharmaceuticals, Insilico Medicine, Isomorphic Labs, Generate:Biomedicines, Schrödinger, BenevolentAI, Atomwise, XtalPi, Relation Therapeutics.
CRISPR & Gene Editing Core
CRISPR, base editing, and prime editing for genetic disease. Companies: CRISPR Therapeutics, Intellia Therapeutics, Beam Therapeutics, Editas Medicine.
Cell & Gene Therapies Core
CAR-T, cell therapy, and gene therapy manufacturing and delivery. Companies: Sarepta Therapeutics, Regeneron Pharmaceuticals, Gilead Sciences, Vertex Pharmaceuticals, Novartis, Bristol Myers Squibb.
RNA Therapeutics High
mRNA, siRNA, and antisense platforms. Companies: Moderna, BioNTech, Alnylam Pharmaceuticals, Pfizer, AstraZeneca.
Synthetic Biology & Protein Design High
Engineered organisms, synthetic DNA, and de novo protein design. Companies: Ginkgo Bioworks, Twist Bioscience, Codexis, Genomatica, Arzeda, Cambrium, Solugen.
Precision Medicine, Multi-Omics, Spatial & Single-Cell High
Genomics, proteomics, transcriptomics, spatial biology, and single-cell sequencing for precision treatment. Companies: Illumina, 10x Genomics, Pacific Biosciences, Oxford Nanopore Technologies, Tempus AI, Foundation Medicine, Natera, Guardant Health.
Digital Biology, Lab Automation & Biomanufacturing Innovation High
Lab robotics, cloud labs, digital twins, and next-gen biomanufacturing. Companies: Benchling, Dotmatics, Thermo Fisher Scientific, Danaher, Sartorius, Lonza, Samsung Biologics, WuXi Biologics, Fujifilm Diosynth Biotechnologies.
Industry Market Intelligence
- Global pharmaceutical R&D investment: R&D spend, pipeline depth, and therapeutic area focus
- Biotechnology funding & venture capital: Biotech VC, crossover, IPO, and private funding cycles
- Pipelines & clinical trials: Phase, indication, readout, and attrition
- M&A, licensing & partnerships: Acquisitions, licensing deals, and tech + life sciences partnerships
- Manufacturing capacity: Biologics capacity, CDMO utilization, and supply-chain dependencies
- Patent expirations & generics: Loss of exclusivity, biosimilars, and generic competition
- AI-driven R&D: AI partnerships, platform deals, and computational drug development
- Regulatory & market access: Approvals, pricing, reimbursement, and market access
- Global supply chain: Manufacturing geography, reagents, instruments, and dependencies
Strategic Analysis
- Who owns the discovery platform — pharma, biotech, or AI company?
- Can AI drug discovery compress timelines enough to change pipeline economics?
- Will cell and gene therapy manufacturing scale — or stay bottlenecked?
- Where does biomanufacturing capacity concentrate — and who controls it?
- How do patent cliffs, biosimilars, and pricing reshape Big Pharma strategy?
Related CODEW Coverage
- Industry Intelligence — Parent hub
- Semiconductor Intelligence — Instruments, sensors, and compute for life sciences
- Healthcare Intelligence — Care delivery, providers, and health systems
- AI Systems Intelligence — AI, agents, and computational biology
- Startup Intelligence — Life sciences startups, funding, and spotlight
- VC Intelligence — Biotech investors, funds, deals, and portfolios
Editorial Scope & How This Directory Is Maintained
- What it covers: Companies, platforms, segments, and technologies — not individual company profiles
- What it does not cover: Medical advice, treatment recommendations, or clinical guidance
- Verification: Check corporate ownership, mergers, acquisitions, operating status, and segment relevance before publishing. Historical companies are labeled Historical.
- Duplication rule: Companies across segments are listed under the primary segment, with cross-reference. Avoid unnecessary duplication.
- Update cadence: Review and expand monthly. Individual company analysis, funding histories, and strategic research are developed as separate CODEW articles and intelligence resources.
The CODEW Lens: Life sciences is not about one breakthrough. It is about platforms, pipelines, manufacturing, and time — turning biology into medicine, at scale.
No comments: